References

• 2008Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults1,940 cited
• 2001Chronic Insomnia Is Associated with Nyctohemeral Activation of the Hypothalamic-Pituitary-Adrenal Axis: Clinical Implications884 cited
• 2002Place of chronic insomnia in the course of depressive and anxiety disorders873 cited
• 2008Prevalence, Course, and Comorbidity of Insomnia and Depression in Young Adults833 cited
• 2002Primary insomnia: a risk factor to develop depression?641 cited
• 2000Meta-analysis of benzodiazepine use in the treatment of insomnia.612 cited
• 199524-Hour Metabolic Rate in Insomniacs and Matched Normal Sleepers557 cited
• 2014Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial519 cited
• 2005Prospective Longitudinal Associations Between Persistent Sleep Problems in Childhood and Anxiety and Depression Disorders in Adulthood478 cited
• 2005An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia434 cited
• 2012Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration313 cited
• 1988Daytime Alertness in Patients with Chronic Insomnia Compared with Asymptomatic Control Subjects303 cited
• 2004Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia